KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.3.

  • Pfizer's Debt Ratio fell 427.72% to 0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3, marking a year-over-year decrease of 427.72%. This contributed to the annual value of 0.3 for FY2024, which is 538.58% down from last year.
  • According to the latest figures from Q3 2025, Pfizer's Debt Ratio is 0.3, which was down 427.72% from 0.3 recorded in Q2 2025.
  • Over the past 5 years, Pfizer's Debt Ratio peaked at 0.89 during Q4 2022, and registered a low of 0.18 during Q4 2022.
  • Over the past 5 years, Pfizer's median Debt Ratio value was 0.3 (recorded in 2023), while the average stood at 0.33.
  • The largest annual percentage gain for Pfizer's Debt Ratio in the last 5 years was 7486.07% (2023), contrasted with its biggest fall of 6681.95% (2023).
  • Pfizer's Debt Ratio (Quarter) stood at 0.21 in 2021, then fell by 13.94% to 0.18 in 2022, then surged by 74.86% to 0.32 in 2023, then fell by 5.39% to 0.3 in 2024, then dropped by 2.08% to 0.3 in 2025.
  • Its last three reported values are 0.3 in Q3 2025, 0.3 for Q2 2025, and 0.3 during Q1 2025.